Conbercept
Conbercept is a pharmaceutical drug with 20 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
5
Mid Stage
7
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
2
trials recruiting
20
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Efficacy and Safety of Conbercept for Diabetic Macular Edema Combined With Severe Non-proliferative Diabetic Retinopathy
Efficacy and Safety of Low-dose Conbercept for Retinopathy of Prematurity Therapy
Evaluation of RC28-E Injection in Diabetic Macular Edema
Conbercept for Polypoidal Choroidal Vasculopathy（START Study）
Anti-VEGF in Real-world
Clinical Trials (20)
Efficacy and Safety of Conbercept for Diabetic Macular Edema Combined With Severe Non-proliferative Diabetic Retinopathy
Efficacy and Safety of Low-dose Conbercept for Retinopathy of Prematurity Therapy
Evaluation of RC28-E Injection in Diabetic Macular Edema
Conbercept for Polypoidal Choroidal Vasculopathy（START Study）
Anti-VEGF in Real-world
Effects of Adding Triamcinolone Acetonide to Conbercept Treatment for Refractory Diabetic Macular Edema (CONTE)
Efficacy and Safety of "Treat-and-Extend" Regimen Versus "Pro Re Nata" of Conbercept in Age-related Macular Degeneration
Conbercept Injection in Treatment of Severe Proliferative Diabetic Retinopathy
Initial Versus Delayed PDT Combination With Conbercept in PCV
Application of Intravitreal Conbercept Injection as a Primary Treatment for Exudative Circumscribed Choroidal Haemangioma
Intravitreal Conbercept After Vitrectomy
PRP vs PRP+IVC for Severe nPDR
Safety and Effectiveness of Intravitreal Conbercept for Exudative Circumscribed Choroidal Haemangioma
Head to Head Study of Anti-VEGF Treatment.
The Efficacy Assessment of Intravitreal Injection of Conbercept in Patients With Polypoidal Choroidal Vasculopathy (PCV)
Conbercept in Choroidal Neovascularization Secondary to Uveitis
Intravitreal Conbercept for Idiopathic Choroidal Neovascularization
Safety and Efficacy Study of Conbercept in Diabetic Macular Edema (DME) (Sailing)
An Open, Single-center, Safety and Efficacy Study of Conbercept in Patients With Very Low Vision Secondary to Wet Age-related Macular Degeneration (wAMD)
Efficacy and Safety of Conbercept in Macular Edema Secondary to Retinal Vein Occlusion
All 20 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 20